Comparison of mucormycosis infection between patients with and without a history of COVID-19 infection: a retrospective cohort study.
Mohammad Hassan Gholampoor SaadiSeyed Ali HosseiniZohre KhodamoradiMaryam MokhtaryanNavid OmidifarMohsen MoghadamiPublished in: Transactions of the Royal Society of Tropical Medicine and Hygiene (2022)
In the pre-COVID-19 era, mucormycosis mainly affected immunodeficient patients like those receiving chemotherapy due to malignancy but now seems to affect COVID-19 patients with uncontrolled blood glucose and glucocorticoids use. Special care must be taken in prescribing glucocorticoids and controlling the blood glucose levels of COVID-19 patients.